Cargando…
Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
Haloperidol is considered the first-line treatment for delirium in critically ill patients. However, clinical evidence of efficacy is lacking and no pharmacokinetic studies have been performed in intensive care unit (ICU) patients. The aim of this study was to establish a pharmacokinetic model to de...
Autores principales: | Li, Letao, Sassen, Sebastiaan D. T., van der Jagt, Mathieu, Endeman, Henrik, Koch, Birgit C. P., Hunfeld, Nicole G. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950491/ https://www.ncbi.nlm.nih.gov/pubmed/35335925 http://dx.doi.org/10.3390/pharmaceutics14030549 |
Ejemplares similares
-
Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19
por: Smeets, Tim J. L., et al.
Publicado: (2022) -
Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It?
por: Li, Letao, et al.
Publicado: (2023) -
Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients
por: Abdulla, Alan, et al.
Publicado: (2020) -
Haloperidol, clonidine and resolution of delirium in critically ill patients: a prospective cohort study
por: Smit, Lisa, et al.
Publicado: (2021) -
Dose optimization of cefotaxime as pre‐emptive treatment in critically ill adult patients: A population pharmacokinetic study
por: Roelofsen, Eveline E., et al.
Publicado: (2022)